NewsRx

Search our medical news database

Medical News Article on HIV/AIDS

Chembio Files Final Module of Premarket Approval Application With FDA for DPP Point-of-Care HIV 1/2 Rapid Test

2012 JUN 18 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Chembio Diagnostics, Inc. (NASDAQ: CEMI) (OTCQB: CEMID) (PINKSHEETS: CEMI), which develops, manufactures, markets and licenses point-of-care diagnostic tests, reports it has filed the final module of its Premarket Approval (PMA) application with the U.S. Food and Drug Administration (FDA) for the Company's DPP® HIV 1/2 Assay. This module contains clinical data from the Company's 3,000-patient pivotal clinical trial for the product.

"We are delighted to submit the final module of our PMA, and look forward to a favorable response from the FDA by year end in order to...

In order to view the entire article, please read your options to the right

Purchase this Article

Price: $3.00


NewsRx Customer?

If you have an account with NewsRx and have purchased either a NewsRx Bundled package or a NewsRx Pass, you can log into your account below to access this article.

Email:

Password:

New to NewsRx?

If you are new to NewsRx, you may also take advantage of cost-saving options such as those below to view this article.

Purchase a NewsRx Pass

View an unlimited number of articles for a day, week, month, etc.

Purchase NewsRx Bundled

Purchase a bundle of article-viewing-credits that never expire and receive a discount of up to 50%!

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook